Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 4, 2025

Construction of an engineered Escherichia coli with enhanced intestinal colonization and anti-inflammatory efficacy in colitis

View Full Paper
Ask AI
Bookmark
Share

Authors

PYPeijun YuWZWenjing ZhouCLChunyang Li

Discussion

Loading...

Member takes

Overview

Engineered probiotics improve intestinal colonization and alleviate colitis symptoms, indicating potential for tailored treatments.

Key Points

  • An engineered escherichia coli strain shows enhanced intestinal colonization and anti-inflammatory efficacy in colitis.
  • Colitis mice treated with the engineered strain experienced decreased disease severity and improved gut microbiome.
  • The strain was modified for better tolerance to gastric acid and bile salts, boosting its probiotic effectiveness.
  • Establishing this platform for synthetic probiotics may advance therapeutic strategies for gastrointestinal diseases.

Cite This Study

Yu et al. (2025) studied this question.

synapsesocial.com/papers/689a0f8de6551bb0af8d0c61https://doi.org/10.1101/2025.08.01.668021
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bioengineering a probiotic to bloom during colonic inflammation promotes reliable efficacy in translational models of colitis.2026
  2. 2Establishment of the improved colonization of Escherichia coli laboratory strain in the intestine mediated by single gene deletion2024 · 2 citations
  3. 3Adhesion‐Enhanced Engineered Probiotic for Prolonged Intestinal Retention and Calprotectin‐Responsive IBD Therapy2026
  4. 4Surface decoration of bacteria generates robust living therapeutics for improved ulcerative colitis therapy2026 · 1 citations
  5. 5Systems Metabolic Engineering to Elucidate and Enhance Intestinal Metabolic Activities of <i>Escherichia coli</i> Nissle 19172024 · 9 citations